DTC
BMY icon

Davidson Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Davidson Trust Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$736K Buy
12,141
+250
+2% +$14.6K 0.32% 82
2025
Q4 		$641K Sell
11,891
-1,695
-12% -$81.5K 0.27% 93
2025
Q3 		$613K Buy
13,586
+1,150
+9% +$53.7K 0.25% 91
2025
Q2 		$576K Sell
12,436
-1,628
-12% -$79.9K 0.27% 90
2025
Q1 		$858K Buy
14,064
+1,285
+10% +$74.9K 0.41% 62
2024
Q4 		$723K Buy
12,779
+222
+2% +$12.4K 0.37% 65
2024
Q3 		$650K Buy
12,557
+203
+2% +$9.52K 0.33% 72
2024
Q2 		$513K Buy
12,354
+829
+7% +$37.1K 0.35% 78
2024
Q1 		$625K Buy
11,525
+563
+5% +$28.7K 0.36% 73
2023
Q4 		$562K Buy
10,962
+204
+2% +$10.7K 0.36% 71
2023
Q3 		$624K Buy
10,758
+137
+1% +$8.39K 0.46% 54
2023
Q2 		$679K Hold
10,621
– – 0.49% 53
2023
Q1 		$736K Buy
10,621
+2,090
+24% +$147K 0.57% 47
2022
Q4 		$614K Hold
8,531
– – 0.54% 49
2022
Q3 		$606K Sell
8,531
-65
-0.8% -$4.71K 0.58% 48
2022
Q2 		$662K Sell
8,596
-320
-4% -$24.4K 0.59% 49
2022
Q1 		$651K Sell
8,916
-360
-4% -$24.2K 0.48% 58
2021
Q4 		$578K Buy
9,276
+331
+4% +$19.4K 0.4% 67
2021
Q3 		$529K Buy
8,945
+275
+3% +$18.1K 0.4% 66
2021
Q2 		$579K Sell
8,670
-717
-8% -$46.8K 0.45% 63
2021
Q1 		$592K Buy
9,387
+60
+0.6% +$3.73K 0.5% 59
2020
Q4 		$577K Hold
9,327
– – 0.5% 58
2020
Q3 		$561K Sell
9,327
-70
-0.7% -$4.21K 0.51% 57
2020
Q2 		$552K Hold
9,397
– – 0.54% 55
2020
Q1 		$523K Buy
9,397
+607
+7% +$37.1K 0.65% 47
2019
Q4 		$564K Buy
+8,790
New +$503K 0.57% 50

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Davidson Trust Company's BMY Position: Q1 2026 in Review

Davidson Trust Company increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q1 2026, buying an estimated $14.6K and bringing the position to 12,141 shares worth $736K. The position accounts for 0.32% of the portfolio, ranked #82.

Davidson Trust Company first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $858K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Davidson Trust Company held 12,141 shares of Bristol-Myers Squibb worth $736K as of Q1 2026.
  • Davidson Trust Company bought 250 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.6K.
  • Bristol-Myers Squibb made up 0.32% of Davidson Trust Company's portfolio in Q1 2026, its #82 holding.
  • Davidson Trust Company first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • Davidson Trust Company's Bristol-Myers Squibb position peaked at $858K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Davidson Trust Company's 13F filing for Q1 2026, filed 20 Apr 2026.